Star Lake Bioscience Co., Inc.Zhaoqing Guangdong

Equities

600866

CNE000000H46

Food Processing

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
5.04 CNY -0.98% Intraday chart for Star Lake Bioscience Co., Inc.Zhaoqing Guangdong +20.86% +8.15%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
China stocks down, dragged by cyclical shares; HK shares up RE
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Full Year Ended December 31, 2023 CI
CJ Cheiljedang Files 20 Million Yuan Patent Case Against Star Lake Bioscience's Unit MT
Guangxin Bio-Intelligent Manufacturing Technology Innovation Co., Ltd. announced that it has received CNY 120 million in funding from Star Lake Bioscience Co., Inc.Zhaoqing Guangdong, Guangdong Guangxin Innovation Research Institute Co., Ltd. CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong cancelled the transaction announced on March 20, 2022 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong(XSSC:600866) added to S&P Global BMI Index CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong completed the acquisition of a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers. CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Star Lake Bioscience to Raise $208 Million for Biotech Firm Purchase MT
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Guangdong Hardware Mineral Import & Export Group Co., Ltd. signed a share transfer contract to acquire 46.43% stake in Guangdong Star Lake New Material Co., Ltd. from Star Lake Bioscience Co., Inc.Zhaoqing Guangdong. CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong announced that it expects to receive CNY 1.5 billion in funding CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong signed a Letter of Intent to acquire a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers for approximately CNY 5.376 billion. CI
Xingfa Aluminium to Pay Nearly $2 Million for Minority Stake in Technology Services Provider MT
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong, FSPG Hi-Tech CO., Ltd. and Xingfa Aluminium Holdings Limited (SEHK:98) signed an agreement to acquire 10% stake in Guangdong Guangxin Innovation Research Institute Co., Ltd. from Guangdong Guangxin Holdings Group Ltd. for CNY 33.5 million. CI
Guangdong Yuexin Asset Management Co., Ltd. agreed to acquire 12.8965 stake in Zhaoqing Duanzhou Huize Enterprise Management Co., Ltd., Zhaoqing Huistar Enterprise Management Consulting Co., Ltd., Zhaoqing Duanzhou Huida Enterprise Management Co., Ltd and Zhaoqing Duanzhou Runze Microfinance Co., Ltd. from Star Lake Bioscience Co., Inc.Zhaoqing Guangdong for CNY 20 million. CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Chart Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
More charts
STAR LAKE BIOSCIENCE CO., INC. ZHAOQING GUANGDONG is a China-based company principally engaged in the bio-chemical and bio-fermentation business. The Company's principal products are biochemical drugs, feed additives and food additives, including nucleotide additives, amino acid feed additives, nucleoside and nucleotide bulk pharmaceutical chemicals (BPCs), as well as amino acid BPC and intermediates. The Company mainly sells its products in domestic and overseas markets.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600866 Stock
  4. News Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
  5. Star Lake Bioscience to Raise $208 Million for Biotech Firm Purchase